Comparison of Fiberoptic Intubation With Fiberoptic Intubation Through an Air-Q Intubating Laryngeal Airway in Infants and Small Children

July 29, 2013 updated by: Narasimhan Jagannathan, Ann & Robert H Lurie Children's Hospital of Chicago

A Randomized Comparison of Free-handed Fiberoptic Intubation Compared With Fiberoptic Intubation Through an Air-QTM Intubating Laryngeal Airway in Children Less Than Two Years of Age: Does Operator Experience Affect Time to Successful Tracheal Intubation?

The goal of this prospective randomized study is to compare the effect of operator experience on the ability to use fiberoptic-guided intubation in children less than two years old, with and without the use of an air-Q as a conduit. The question the investigators are trying to answer is: Does the operator experience make a significant difference in the time for successful fiberoptic guided tracheal intubation with and without the use of an air-Q intubating laryngeal airway?

Study Overview

Detailed Description

The aim of this study is to compare the effect of operator experience on the ability to use fiberoptic-guided intubation in children less than two years old, with and without the use of an air-Q as a conduit. The ease and time for placement of the air-Q, fiberoptic grade of laryngeal view, time for fiberoptic tracheal intubation, and peri-operative complications will also be assessed.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Ann & Robert H. Lurie Children's Hospital of Chicago

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 2 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy (ASA I to III) children who will be intubated as part of their general anesthesia plan for their scheduled surgeries
  • Age 1 month - 2 years
  • Weight 1-20 Kg

Exclusion Criteria:

  • Children with active respiratory infection
  • Known history of difficult mask ventilation
  • Diagnosis of a congenital syndrome associated with difficult airway management
  • Airway abnormalities (e.g., laryngomalacia, subglottic stenosis).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fiberoptic Intubation performed by an expert
Tracheal intubation will be performed by an expert anesthesia attending with and without use of the air-Q
Other Names:
  • Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed
Fiberoptic tracheal intubation will be performed without use of the air-Q and timed. Laryngeal grade of view will also be assessed
Experimental: Fiberoptic Intubation performed by a novice
Tracheal intubation will be performed by an anesthesia trainee with and without use of the air-Q
Other Names:
  • Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed
Fiberoptic tracheal intubation will be performed without use of the air-Q and timed. Laryngeal grade of view will also be assessed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time for successful fiberoptic tracheal intubation
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The time for successful intubation will be from removal of the face mask or disconnection of the circuit from the air-Q until evidence of end-tidal CO2 is confirmed.
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fiberoptic grade of laryngeal view
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The laryngeal alignment through the devices will be graded using an established scoring system
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Time to successful placement of the Air-Q
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Successful placement of the air-Q will start with the removal of the facemask until presence of end-tidal CO2 is confirmed.
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Number of attempts to place the Air-Q
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Number of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure)
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Ease for placement of the air-Q
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The ease for Air-Q placement will be assessed using a subjective scale
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Peri-operative complications
Time Frame: Measured at 24 hours after device placement/study initiation
Includes: Complications during the placement of the Air-Q (Laryngospasm, Bronchospasm, Desaturation, etc. Oropharyngolaryngeal morbidity at discharge, participants will be followed for the duration of anesthesia and after surgery, an average of 24 hours. Oropharyngolaryngeal morbidity at 24 hours post-operatively, measured at 24 hours after device placement/study initiation. These will be assessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort.
Measured at 24 hours after device placement/study initiation
Number of attempts for fiberoptic tracheal intubation
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Number of attempts needed for successful fiberoptic tracheal intubation will be recorded (maximum of 3 attempts will be considered as a failure)
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Ease for fiberoptic tracheal intubation
Time Frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The ease for fiberoptic tracheal intubation will be assessed using a subjective scale
Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Narasimhan Jagannathan, MD, Ann & Robert H Lurie Children's Hospital of Chicago
  • Principal Investigator: Lisa Sohn, MD, Ann & Robert H Lurie Children's Hospital of Chicago

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

July 1, 2013

Study Completion (Actual)

July 1, 2013

Study Registration Dates

First Submitted

June 11, 2013

First Submitted That Met QC Criteria

June 12, 2013

First Posted (Estimate)

June 13, 2013

Study Record Updates

Last Update Posted (Estimate)

July 30, 2013

Last Update Submitted That Met QC Criteria

July 29, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • IRB#2013-15391

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fiberoptic Intubation in Children

Clinical Trials on air-Q, followed by fiberoptic intubation

3
Subscribe